tiprankstipranks
Trending News
More News >
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market

Crispr Therapeutics AG (CRSP) Ratios

Compare
9,509 Followers

Crispr Therapeutics AG Ratios

CRSP's free cash flow for Q1 2025 was $-65.48. For the 2025 fiscal year, CRSP's free cash flow was decreased by $ and operating cash flow was $-171.59. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
17.29 17.54 15.30 20.17 18.21
Quick Ratio
17.29 17.54 15.39 20.17 18.21
Cash Ratio
16.53 3.58 1.75 7.70 12.40
Solvency Ratio
0.56 -0.39 -1.70 1.12 -2.07
Operating Cash Flow Ratio
0.99 -2.39 -4.09 4.50 -2.53
Short-Term Operating Cash Flow Coverage
6.68 -9.30 -31.29 44.33 -20.98
Net Current Asset Value
$ 860.22M$ 1.56B$ 1.49B$ 2.07B$ 1.55B
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.11 0.11 0.08 0.03
Debt-to-Equity Ratio
0.06 0.13 0.13 0.09 0.04
Debt-to-Capital Ratio
0.05 0.11 0.12 0.09 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.14 1.18 1.20 1.15 1.10
Debt Service Coverage Ratio
6.01 -7.35 -40.95 32.05 -30.46
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.97 3.01 3.14 2.96 0.93
Net Debt to EBITDA
-17.32 0.74 -0.05 -1.78 3.21
Profitability Margins
Gross Profit Margin
38.06%64.91%-25186.70%98.03%-49514.55%
EBIT Margin
16.14%-59.95%-154394.72%40.91%-65273.48%
EBITDA Margin
17.77%-54.61%-148850.69%42.87%-63582.14%
Operating Profit Margin
16.14%-59.95%-154394.72%40.91%-65273.48%
Pretax Profit Margin
23.24%-40.60%-149197.25%41.57%-64098.71%
Net Profit Margin
23.09%-41.38%-149122.71%41.36%-64247.70%
Continuous Operations Profit Margin
23.09%-41.38%-149122.71%41.36%-64247.70%
Net Income Per EBT
99.33%101.92%99.95%99.51%100.23%
EBT Per EBIT
144.00%67.73%96.63%101.61%98.20%
Return on Assets (ROA)
6.27%-6.89%-28.99%13.72%-19.08%
Return on Equity (ROE)
7.12%-8.16%-34.67%15.74%-20.96%
Return on Capital Employed (ROCE)
4.63%-10.49%-31.72%14.19%-20.44%
Return on Invested Capital (ROIC)
4.52%-10.48%-31.24%13.99%-20.23%
Return on Tangible Assets
6.27%-6.89%-28.99%13.72%-19.09%
Earnings Yield
2.02%-3.10%-20.57%6.56%-3.45%
Efficiency Ratios
Receivables Turnover
2.93K 1.86 0.00 2.99K 3.77
Payables Turnover
30.18 3.41 4.02 1.21 29.62
Inventory Turnover
179.36M 0.00 -9.84 0.00 0.00
Fixed Asset Turnover
3.98 1.21 <0.01 2.93 <0.01
Asset Turnover
0.27 0.17 <0.01 0.33 <0.01
Working Capital Turnover Ratio
0.42 0.21 <0.01 0.47 <0.01
Cash Conversion Cycle
-11.97 89.76 -127.88 -301.10 84.47
Days of Sales Outstanding
0.12 196.66 0.00 0.12 96.80
Days of Inventory Outstanding
<0.01 0.00 -37.08 0.00 0.00
Days of Payables Outstanding
12.10 106.90 90.80 301.22 12.32
Operating Cycle
0.12 196.66 -37.08 0.12 96.80
Cash Flow Ratios
Operating Cash Flow Per Share
1.04 -3.29 -6.38 7.10 -3.61
Free Cash Flow Per Share
0.92 -3.44 -6.85 6.02 -3.89
CapEx Per Share
0.12 0.15 0.48 1.08 0.28
Free Cash Flow to Operating Cash Flow
0.88 1.05 1.08 0.85 1.08
Dividend Paid and CapEx Coverage Ratio
8.48 -21.75 -13.33 6.60 -12.98
Capital Expenditure Coverage Ratio
8.48 -21.75 -13.33 6.60 -12.98
Operating Cash Flow Coverage Ratio
1.08 -1.09 -2.03 2.40 -3.88
Operating Cash Flow to Sales Ratio
0.20 -0.70 -1.14K 0.59 -438.98
Free Cash Flow Yield
1.51%-5.49%-16.86%7.95%-2.54%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
49.55 -32.28 -4.86 15.24 -28.94
Price-to-Sales (P/S) Ratio
11.44 13.36 7.25K 6.30 18.60K
Price-to-Book (P/B) Ratio
3.53 2.63 1.69 2.40 6.07
Price-to-Free Cash Flow (P/FCF) Ratio
66.26 -18.21 -5.93 12.59 -39.33
Price-to-Operating Cash Flow Ratio
58.45 -19.05 -6.38 10.68 -42.36
Price-to-Earnings Growth (PEG) Ratio
-0.36 0.42 0.02 -0.08 0.05
Price-to-Fair Value
3.53 2.63 1.69 2.40 6.07
Enterprise Value Multiple
47.05 -23.72 -4.92 12.92 -26.04
Enterprise Value
2.42B 4.81B 3.19B 5.06B 8.99B
EV to EBITDA
47.05 -23.72 -4.92 12.92 -26.04
EV to Sales
8.36 12.95 7.32K 5.54 16.56K
EV to Free Cash Flow
48.44 -17.66 -5.99 11.06 -35.02
EV to Operating Cash Flow
42.73 -18.47 -6.44 9.38 -37.72
Tangible Book Value Per Share
17.27 23.77 24.12 31.59 25.23
Shareholders’ Equity Per Share
17.27 23.77 24.12 31.59 25.23
Tax and Other Ratios
Effective Tax Rate
<0.01 -0.02 <0.01 <0.01 >-0.01
Revenue Per Share
5.32 4.69 <0.01 12.02 <0.01
Net Income Per Share
1.23 -1.94 -8.36 4.97 -5.29
Tax Burden
0.99 1.02 1.00 1.00 1.00
Interest Burden
1.44 0.68 0.97 1.02 0.98
Research & Development to Revenue
0.62 1.04 1.06K 0.48 491.61
SG&A to Revenue
0.22 0.21 235.01 0.11 162.45
Stock-Based Compensation to Revenue
0.15 0.22 224.65 0.11 121.58
Income Quality
0.85 1.70 0.76 1.43 0.68
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis